Patients in the US and EU with follicular lymphoma (FL) have new treatment options, thanks to regulatory approvals for Roche's Lunsumio and AbbVie/Genmab's Epkinly. First up, the European Commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results